To the Editor In their Original Investigation in a recent issue of JAMA Internal Medicine, Dr Uranga and colleagues1 reported that patient outcomes were not significantly different when antibiotic treatment was discontinued based on clinical stability criteria after a minimum of 5 days of appropriate treatment compared with standard treatment length as determined by physicians. They concluded that the shorter course of treatment was not inferior and that the Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) guidelines regarding the duration of antibiotic treatment can be safely implemented among hospitalized patients with community-acquired pneumonia.1
Mori T, Yaegashi M, Hasegawa S. Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy. JAMA Intern Med. 2017;177(2):284. doi:10.1001/jamainternmed.2016.8577
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: